heart
3D printed hearts ‘on the horizon’
May 8, 2014Medical Communications, Sales and Marketing 3D, heart, louisville, printing, williams
The ‘inherent design flaws’ of the human heart could become a thing of the past as new 3D printing technology …
EMA to conduct major review into testosterone drugs
April 14, 2014Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone
The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …
FDA unconvinced on Novartis heart drug
March 26, 2014Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin
The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …
Reprieve for Merck’s vorapaxar
January 16, 2014Sales and Marketing FDA, Merck, heart, vorapaxar
An FDA committee has voted that Merck’s troubled heart drug vorapaxar should be approved by the US regulator. The advisory …
GSK heart disease drug fails late-stage trial
November 13, 2013Sales and Marketing GSK, darapladib, heart, statin
GSK has said its investigational chronic coronary heart disease pill darapladib has failed to meet its primary endpoint in a …
EMA questions Brilinta data
November 8, 2013Sales and Marketing Brilinta, EMA, astrazenca, heart, ticagrelor
The European Medicines Agency is demanding more information from AstraZeneca on its troubled heart pill Brilinta. This rounds off a …
Amgen signs Servier deal
July 11, 2013Sales and Marketing Amgen, Servier, heart, procoloran
Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …
Latest content
Five Facts about cardiovascular disease
